Cannabis Bioscience International Holdings ( (CBIH) ) has released a notification of late filing.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cannabis Bioscience International Holdings has filed a Form 12b-25, indicating a delay in filing its Form 10-Q (Quarter Report) for the financial period ending August 31, 2025. The primary reason for the delay is the inability to analyze and complete the financial information on time. The company anticipates filing the report within five calendar days following the prescribed due date. Financially, the company expects a significant change in results, with an estimated loss from operations of approximately $66,000 for the three months ended August 31, 2025, compared to a loss of $97,604 for the same period in 2024. Revenues and gross profit are also expected to decrease significantly. Cannabis Bioscience International Holdings is actively working towards compliance, with the notification signed by CEO Dante Picazo.
More about Cannabis Bioscience International Holdings
Current Market Cap: $5.23M
See more insights into CBIH stock on TipRanks’ Stock Analysis page.